NCT05318690

Brief Summary

PlayGait is an investigational dynamic energy storage and return (ESR) lower-limb exoskeleton for young children with cerebral palsy (CP), that stores energy while the child is in the stance phase of walking and returns that energy in terminal stance and early swing phase of walking. PlayGait assists with the passive dynamics of walking through an exotendon (comprised of a spring in series with a cable). The overall objective of this investigational device is to promote correct walking patterns that encourage proper bone alignment, muscle recruitment, and strengthening during walking practice in young children with CP. The study will evaluate children with CP's activity levels in the community with and without PlayGait. The study will consist of three lab visits and two, 7-day periods at home.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2022

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 8, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2023

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

10 months

First QC Date

March 24, 2022

Last Update Submit

October 6, 2023

Conditions

Keywords

pediatricorthosisexoskeleton

Outcome Measures

Primary Outcomes (2)

  • Cadence

    Low, medium, and high activity rate

    7 days with baseline condition; 7 days with PlayGait condition

  • Shifts in cadence

    Shifts from low to medium cadence and shifts from medium to high cadence

    7 days with baseline condition; 7 days with PlayGait condition

Secondary Outcomes (5)

  • 1 minute walk test

    1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait

  • 10 meter walk test

    1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait

  • Pediatric Balance Scale

    1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait

  • Average steps per day

    Baseline Condition: 7 days in the community without PlayGait (no lower-limb assistive devices); PlayGait condition: 7 days with PlayGait

  • Time of PlayGait use

    PlayGait condition: 7 days in the community with PlayGait

Study Arms (2)

PlayGait (Exoskeleton)

EXPERIMENTAL

Experimental lower-limb device.

Device: PlayGait

Baseline

ACTIVE COMPARATOR

Baseline condition without using any prescribed lower-limb orthoses.

Other: Baseline

Interventions

PlayGaitDEVICE

PlayGait is a dynamic energy storing and returning lower-limb exoskeleton.

PlayGait (Exoskeleton)

Baseline condition with no prescribed or intervention lower-limb devices.

Baseline

Eligibility Criteria

Age3 Years - 4 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 3 - 4 years (at time of informed consent)
  • Hemiplegic cerebral palsy
  • If child uses an ankle-foot orthosis (AFO), parent/caregiver is willing to have the child stop wearing their prescribed AFO during data collections (lab sessions and two 7-day periods at home)
  • Ability to walk at least 10 meters without the use of assistive devices or AFOs
  • Ability to walk at least 1 minute without the use of assistive devices or AFOs
  • Stiff knee gait - less than normal knee flexion during swing phase
  • Hip flexion passive range of motion contracture less than 20 degrees
  • Gross Motor Function Classification System (GMFCS) Levels I-II
  • Modified Ashworth Scale (MAS) \<=2 for the gastrocnemius soleus, rectus femoris, and hamstrings
  • Family has resources to attend all study sessions (transportation, schedule)
  • Ability to speak and understand in English

You may not qualify if:

  • Orthopedic surgery in the last year
  • Foster children or wards of the state
  • Use wheelchair or stroller mobility as their primary method of independent mobility
  • Severe visual impairment such that the visual impairment itself functionally limits mobility
  • Phenol or Botox injections to the legs in the last 3 months
  • Uncontrolled seizure disorder, defined as any seizure in the last 3 months that influenced mobility skills and function (seizures which did not affect mobility are acceptable)
  • Lower limb fracture in the last 3 months
  • Planned surgery or changes to movement disorder medication during the study period
  • Inability to understand directions sufficiently to complete the study assessments
  • Cognitive, behavioral, or any other issues that may not allow for effective study participation
  • Unwilling to complete the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orthocare Innovations, LLC

Edmonds, Washington, 98020, United States

Location

MeSH Terms

Conditions

Cerebral Palsy

Interventions

BaseLine dental cement

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Jessica Zistatsis, MSME

    Orthocare Innovations

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2022

First Posted

April 8, 2022

Study Start

March 11, 2022

Primary Completion

January 3, 2023

Study Completion

January 3, 2023

Last Updated

October 10, 2023

Record last verified: 2023-10

Locations